- Home
- BGH vs QTRX Comparison
BGH vs QTRX Comparison
Compare BGH & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGH
- QTRX
- Stock Information
- Founded
- BGH 2012
- QTRX 2007
- Country
- BGH United States
- QTRX United States
- Employees
- BGH N/A
- QTRX N/A
- Industry
- BGH Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- BGH Finance
- QTRX Industrials
- Exchange
- BGH Nasdaq
- QTRX Nasdaq
- Market Cap
- BGH 297.0M
- QTRX 337.7M
- IPO Year
- BGH N/A
- QTRX 2017
- Fundamental
- Price
- BGH $15.03
- QTRX $7.29
- Analyst Decision
- BGH
- QTRX Hold
- Analyst Count
- BGH 0
- QTRX 3
- Target Price
- BGH N/A
- QTRX $10.33
- AVG Volume (30 Days)
- BGH 61.5K
- QTRX 808.8K
- Earning Date
- BGH 01-01-0001
- QTRX 11-10-2025
- Dividend Yield
- BGH 10.06%
- QTRX N/A
- EPS Growth
- BGH N/A
- QTRX N/A
- EPS
- BGH N/A
- QTRX N/A
- Revenue
- BGH N/A
- QTRX $130,203,000.00
- Revenue This Year
- BGH N/A
- QTRX N/A
- Revenue Next Year
- BGH N/A
- QTRX $37.03
- P/E Ratio
- BGH N/A
- QTRX N/A
- Revenue Growth
- BGH N/A
- QTRX N/A
- 52 Week Low
- BGH $11.92
- QTRX $4.05
- 52 Week High
- BGH $14.50
- QTRX $13.01
- Technical
- Relative Strength Index (RSI)
- BGH 47.64
- QTRX 76.82
- Support Level
- BGH $14.66
- QTRX $5.83
- Resistance Level
- BGH $15.22
- QTRX $5.79
- Average True Range (ATR)
- BGH 0.19
- QTRX 0.42
- MACD
- BGH 0.01
- QTRX 0.23
- Stochastic Oscillator
- BGH 55.76
- QTRX 98.34
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.